Concepedia

Beijian Chen

BC

Statistics

Publications

3

Citations

75

H-Index

3

Active since

2023

Affiliations

Yuncheng University(Current)

Peking University First Hospital

Heze Municipal Hospital

Peking University

Shanxi Medical University

Beijian Chen is an author at Yuncheng University specializing in dyslipidemia management, clinical pharmacology, and cardiovascular disease.

Publications per year

2023–2024

3

Publications

3

Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4)

Litong Qi, Dexue Liu, Yanling Qu et al. · JACC Asia · 2023 · 30 citations · Full text

, , +17

Tafolecimab in Chinese patients with non-familial hypercholesterolemia (CREDIT-1): a 48-week randomized, double-blind, placebo-controlled phase 3 trial

Yong Huo, Beijian Chen, Qiufang Lian et al. · The Lancet Regional Health - Western Pacific · 2023 · 28 citations · Full text

, , +17

Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab

Yanyan Zhang, Zhaohui Pei, Beijian Chen et al. · Pharmacological Research · 2024 · 17 citations · Full text

, , +16

1–3 of 3